Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108461911> ?p ?o ?g. }
- W3108461911 endingPage "135" @default.
- W3108461911 startingPage "121" @default.
- W3108461911 abstract "Acute myeloid leukemia (AML) is the most frequently diagnosed acute leukemia, and its incidence increases with age. Although the etiology of AML remains unknown, exposure to genotoxic agents or some prior hematologic disorders could lead to the development of this condition. The pathogenesis of AML involves the development of malignant transformation of hematopoietic stem cells that undergo successive genomic alterations, ultimately giving rise to a full-blown disease. From the disease biology perspective, AML is considered to be extremely complex with significant genetic, epigenetic, and phenotypic variations. Molecular and cytogenetic alterations in AML include mutations in those subsets of genes that are involved in normal cell proliferation, maturation and survival, thus posing significant challenge to targeting these pathways without attendant toxicity. In addition, multiple malignant cells co-exist in the majority of AML patients. Individual subclones are characterized by unique genetic and epigenetic abnormalities, which contribute to the differences in their response to treatment. As a result, despite a dramatic progress in our understanding of the pathobiology of AML, not much has changed in therapeutic approaches to treat AML in the past four decades. Dose and regimen modifications with improved supportive care have contributed to improved outcomes by reducing toxicity-related side effects. Several drug candidates are currently being developed, including targeted small-molecule inhibitors, cytotoxic chemotherapies, monoclonal antibodies and epigenetic drugs. This review summarizes the current state of affairs in the pathobiological and therapeutic aspects of AML." @default.
- W3108461911 created "2020-12-07" @default.
- W3108461911 creator A5016048028 @default.
- W3108461911 creator A5029859331 @default.
- W3108461911 creator A5039450674 @default.
- W3108461911 creator A5043029830 @default.
- W3108461911 creator A5054855160 @default.
- W3108461911 date "2022-08-01" @default.
- W3108461911 modified "2023-10-16" @default.
- W3108461911 title "Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities" @default.
- W3108461911 cites W103419301 @default.
- W3108461911 cites W135651168 @default.
- W3108461911 cites W1489323849 @default.
- W3108461911 cites W1507489869 @default.
- W3108461911 cites W1531899330 @default.
- W3108461911 cites W1542395305 @default.
- W3108461911 cites W1820378590 @default.
- W3108461911 cites W1965253007 @default.
- W3108461911 cites W1966455266 @default.
- W3108461911 cites W1967784191 @default.
- W3108461911 cites W1968031432 @default.
- W3108461911 cites W1969819968 @default.
- W3108461911 cites W1970224079 @default.
- W3108461911 cites W1973023394 @default.
- W3108461911 cites W1973899902 @default.
- W3108461911 cites W1976778821 @default.
- W3108461911 cites W1980860344 @default.
- W3108461911 cites W1981326646 @default.
- W3108461911 cites W1986442247 @default.
- W3108461911 cites W1991687104 @default.
- W3108461911 cites W1992291725 @default.
- W3108461911 cites W1993300766 @default.
- W3108461911 cites W1996501345 @default.
- W3108461911 cites W1998475390 @default.
- W3108461911 cites W2000355031 @default.
- W3108461911 cites W2001142914 @default.
- W3108461911 cites W2001656423 @default.
- W3108461911 cites W2003193974 @default.
- W3108461911 cites W2006116919 @default.
- W3108461911 cites W2007812119 @default.
- W3108461911 cites W2008001245 @default.
- W3108461911 cites W2008735841 @default.
- W3108461911 cites W2010571787 @default.
- W3108461911 cites W2016087553 @default.
- W3108461911 cites W2016934021 @default.
- W3108461911 cites W2018240559 @default.
- W3108461911 cites W2019789998 @default.
- W3108461911 cites W2024460356 @default.
- W3108461911 cites W2025187528 @default.
- W3108461911 cites W2025921295 @default.
- W3108461911 cites W2026043555 @default.
- W3108461911 cites W2030249962 @default.
- W3108461911 cites W2032025865 @default.
- W3108461911 cites W2035576418 @default.
- W3108461911 cites W2037775640 @default.
- W3108461911 cites W2040347441 @default.
- W3108461911 cites W2040852160 @default.
- W3108461911 cites W2041057224 @default.
- W3108461911 cites W2041512814 @default.
- W3108461911 cites W2043721269 @default.
- W3108461911 cites W2044294015 @default.
- W3108461911 cites W2044942890 @default.
- W3108461911 cites W2047122678 @default.
- W3108461911 cites W2049533509 @default.
- W3108461911 cites W2050249118 @default.
- W3108461911 cites W2050595529 @default.
- W3108461911 cites W2051098641 @default.
- W3108461911 cites W2057652101 @default.
- W3108461911 cites W2058188142 @default.
- W3108461911 cites W2060402045 @default.
- W3108461911 cites W2070433411 @default.
- W3108461911 cites W2075910266 @default.
- W3108461911 cites W2077994180 @default.
- W3108461911 cites W2079121920 @default.
- W3108461911 cites W2088294300 @default.
- W3108461911 cites W2088965961 @default.
- W3108461911 cites W2089424961 @default.
- W3108461911 cites W2089686547 @default.
- W3108461911 cites W2089780281 @default.
- W3108461911 cites W2091334048 @default.
- W3108461911 cites W2096781142 @default.
- W3108461911 cites W2100883771 @default.
- W3108461911 cites W2101173691 @default.
- W3108461911 cites W2102423175 @default.
- W3108461911 cites W2102432084 @default.
- W3108461911 cites W2103177765 @default.
- W3108461911 cites W2107925822 @default.
- W3108461911 cites W2108254285 @default.
- W3108461911 cites W2110630778 @default.
- W3108461911 cites W2111279921 @default.
- W3108461911 cites W2111866362 @default.
- W3108461911 cites W2111907637 @default.
- W3108461911 cites W2112414163 @default.
- W3108461911 cites W2113415973 @default.
- W3108461911 cites W2114242622 @default.
- W3108461911 cites W2118781121 @default.
- W3108461911 cites W2120440386 @default.
- W3108461911 cites W2120555830 @default.